Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, June 19, 2026
🇺🇸 FDA

ST316 News

🇺🇸 FDA ← All news

FDA ST316 coverage for business development, investment, and market access teams

Critical impact NewsApr 21, 2026

Sapience Therapeutics ST316 Shows 47% Response Rate in Phase 2 Colorectal Cancer Trial

Oncology - Colorectal Cancer · 3 min

Dr. Sarah Mitchell

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.